Related references
Note: Only part of the references are listed.EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Surgical Resection Versus Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
Po-Hong Liu et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
Thomas Yau et al.
GASTROENTEROLOGY (2014)
Surgical Resection Is Better than Transarterial Chemoembolization for Hepatocellular Carcinoma Beyond Milan Criteria Independent of Performance Status
Po-Hong Liu et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2014)
A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group
Guido Torzilli et al.
ANNALS OF SURGERY (2013)
Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C
Jing-Houng Wang et al.
DIGESTIVE AND LIVER DISEASE (2013)
Liver resection is a therapeutic option for highly selected BCLC C patients in the context of an expert multidisciplinary setting
Umberto Cillo
DIGESTIVE AND LIVER DISEASE (2013)
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
Luigi Bolondi et al.
DIGESTIVE AND LIVER DISEASE (2013)
Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system
Chia-Yang Hsu et al.
HEPATOLOGY (2013)
Vascular Invasion in Hepatocellular Carcinoma
Yun-Hsuan Lee et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus
Zhen-Wei Peng et al.
CANCER (2012)
Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging
Tian Yang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib
Matthias Pinter et al.
RADIOLOGY (2012)
Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: Extending the Indication for resection?
Wen-Tsan Chang et al.
SURGERY (2012)
Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
M. Pinter et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia
Kwang-Hyub Han et al.
ONCOLOGY (2011)
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
Peter C. Austin
PHARMACEUTICAL STATISTICS (2011)
Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Jie Shi et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Selecting an Optimal Staging System for Hepatocellular Carcinoma
Chia-Yang Hsu et al.
CANCER (2010)
A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system
Chia-Yang Hsu et al.
JOURNAL OF HEPATOLOGY (2010)
Strategy of Treatment for Hepatocellular Carcinomas With Vascular Infiltration in Patients Undergoing Hepatectomy
Atsushi Nanashima et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Is it Time to Reconsider the BCLC/AASLD Therapeutic Flow-Chart?
Tito Livraghi et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization
Chia-Yang Hsu et al.
LIVER INTERNATIONAL (2010)
Treatment of Intermediate/Advanced Hepatocellular Carcinoma in the Clinic: How Can Outcomes Be Improved?
Riccardo Lencioni et al.
ONCOLOGIST (2010)
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
Donald Poon et al.
LANCET ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients
Jing-Houng Wang et al.
EUROPEAN JOURNAL OF CANCER (2008)
Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival
Chi-Sin Changchien et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage
YH Huang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study
TI Huo et al.
ANNALS OF ONCOLOGY (2003)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients
S Ueno et al.
HEPATOLOGY (2001)
Share Paper
